02365nam 2200565 a 450 991087772320332120200520144314.01-283-17566-597866131756631-118-02366-81-118-02367-61-118-02365-X(CKB)2550000000041121(EBL)693249(OCoLC)745970855(SSID)ssj0000524794(PQKBManifestationID)12222185(PQKBTitleCode)TC0000524794(PQKBWorkID)10488185(PQKB)11413967(MiAaPQ)EBC693249(PPN)243334850(EXLCZ)99255000000004112120101020d2011 uy 0engur|n|---|||||txtccrPharmaceutical anti-counterfeiting combating the real danger from fake drugs /Mark DavisonHoboken, N.J. John Wiley & Sonsc20111 online resource (428 p.)Description based upon print version of record.0-470-61617-2 Includes bibliographical references and index.pt. 1. General themes -- pt. 2. Authentication -- pt. 3. Product tracking -- pt. 4. Conclusions and the future -- pt. 5. Further Resources.This book overviews and integrates the business and technical issues that pharmaceutical companies need to know in order to combat the major global problem of counterfeit medicines. In addition to discussion of the problems, the author Davison addresses analytical techniques scientists use to detect counterfeits and presents some possible solutions to the threat of counterfeit medical products. Coverage moves from basic overview of the problem, costs / risks to consumers (toxic products, mistrust of drug companies) and business (revenue loss, public trust), government oversight and regulation,Product counterfeitingDrug adulterationProduct counterfeiting.Drug adulteration.615.1068/4Davison Mark1968 Mar. 1-1761835MiAaPQMiAaPQMiAaPQBOOK9910877723203321Pharmaceutical anti-counterfeiting4201491UNINA